⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Panacea Group and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Panacea Group
↗London, United Kingdom
Panacea Group is a UK-based venture building, accelerator, and investment ecosystem operating at the intersection of biology, artificial intelligence, and human insight. The company focuses on creating and scaling Bio-AI companies from scratch, providing infrastructure, investment, and strategic support to scientific founders.
Through its affiliated brands—Panacea Stars (venture builder/accelerator) and Panacea Capital (investment funds)—the firm supports early-stage ventures across various healthcare domains, including cardiovascular and other complex biological fields. They maintain a strong presence in the UK's 'Golden Triangle' with hubs in Oxford and London.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Venture Builder / Accelerator / Investment
SIZE & FINANCIALS
Employees:1-50
Founded:2016
Ownership:private
Status:operating
PIPELINE
Stage:Discovery
Lead Drug Stage:Early-stage venture building
Modalities:AI-driven drug discovery, Digital Health
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Panacea Stars, Panacea Capital
Key Partnerships:British Heart Foundation (Cardio Stars programme)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Will Brooks - Managing Partner
LINKS
Website:panacea-hq.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Panacea Group. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.